Author: Elena Morales

The biologics market was valued at USD 419.07 billion in 2023 and is projected to grow significantly, reaching approximately USD 845.78 billion by 2033. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of 7.6% through 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5108

Biologics Market Report Highlights:

• The biologics market size ballooned to a staggering USD 419.07 billion in 2023.
• It is anticipated to attain USD 845.78 billion by 2033.
• It is expected to register 7.6% of CAGR by 2032.
• Blood and blood products led the market in 2023, capturing a commanding 66% market share.
• Oncology takes center stage, with this application segment leading the pack at 36% share in 2023.
• Asia Pacific is the rising star, predicted to be the fastest-growing region over the next decade.

The American Cancer Society estimates 1.92 million new cancer cases and 609,360 deaths in the U.S., contributing to a global toll of 9.6 million lives lost in 2022. Biologics, monoclonal antibodies, and immunotherapies revolutionize cancer care, boosting survival and minimizing side effects.

Biologics are therapeutic products derived from living organisms or their components, such as cells, proteins, or nucleic acids. Unlike traditional drugs, which are often chemically synthesized, biologics are typically large and complex molecules produced using advanced technologies like genetic engineering. This complexity allows them to closely mimic the natural substances in the human body, making them more targeted and specific in their actions. One significant aspect of biologics is their role in treating diseases at the molecular and cellular levels. They are designed to interact with specific biological pathways and mechanisms, making them highly effective in addressing the underlying causes of various diseases. This targeted approach can result in better treatment outcomes and, in many cases, fewer adverse effects than conventional drugs.

The application of biologics spans a wide range of therapeutic areas. One prominent example is their use in oncology. Monoclonal antibodies, a biologic, have revolutionized cancer treatment by selectively targeting cancer cells while sparing healthy cells. This targeted action helps minimize damage to surrounding tissues and reduces side effects commonly associated with traditional chemotherapy. In autoimmune disorders, where the immune system mistakenly attacks the body’s tissues, biologics can modulate specific immune response components. This helps to restore the balance and alleviate symptoms without suppressing the entire immune system, as is often the case with conventional treatments.

The growth of the biologics market is fueled by ongoing advancements in biotechnology, such as improved techniques for protein engineering and manufacturing processes. These innovations enable the development of novel and more sophisticated biological therapies. It’s important to note that biologics often come with higher production costs and can be more challenging to manufacture than small-molecule drugs. This can result in higher prices for biological treatments. Despite this, the demand for biologics continues to rise due to their ability to provide effective and often life-changing solutions for patients facing various health challenges.

Recent Developments

• In May 2024, using a seed investment of €16 million ($17.2 million), Commit Biologics came out of stealth to develop antibody therapies for the treatment of cancer and autoimmune diseases using their bispecific complement engaging (BiCE) technology. The primary investors were Novo Nordisk’s holding and investment business, Novo Holdings, and the European venture capital firm Bioqube Ventures.
• In March 2024, Bone Biologics, a company that specializes in spine fusion implants, announced an IPO for $2 million. According to a news release dated March 4, the public offering consists of 781,251 shares of the company’s common stock, which is priced at $2.56 per share. According to the firm, the funds obtained would go toward funding clinical research, working capital, general corporate goals, and its portfolio of patents.
• In January 2024, the biosimilar ranibizumab Cimerli (ranibizumab-earn) will be acquired by Sandoz and Coherus BioSciences for an upfront cash acquisition price of $170 million. This includes a product inventory, ophthalmology-specific sales and reimbursement staff, access to exclusive commercial tools, and the ability to apply for a biologics license.
• In April 2023, the biopharmaceutical company TORL BioTherapeutics LLC, which focuses on developing innovative biologics for cancer therapy, announced the completion of a $158 million Series B funding and its official debut. In the laboratory of scientific co-founder Dennis Slamon, who is chairman of the hematology/oncology division and a medical professor at UCLA’s David Geffen School of Medicine (DGSOM), the company’s antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered.
• In 2020, WuXi Biologics bought Bayer’s drug manufacturing facility in Germany, marking its first facility in Europe. This move aimed to boost WuXi Biologics’ ability to produce medications commercially.
• In October 2020, Cadila Pharmaceuticals introduced two similar biologic drugs, NuPTH and Cadalimab, in the Indian market. This step was taken to expand the company’s presence in different regions.

Biologics Market Companies

• Amgen
• Merck & Co.
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb
• Sanofi
• Bayer AG
• AstraZeneca
• GlaxoSmithKline Plc.
• Novartis AG
• Eli Lilly and Company

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/biologics-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5108

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5107

As per John Hopkin Medicine reports, every year, more than 3.5 million kids under 14 get hurt playing sports or having fun; over 775,000 kids in this age group go to the emergency room because of sports-related injuries. Due to the high number of injuries in sports, there’s been an increase in innovation in sports medicine.

The sports medicine market is a multifaceted realm dedicated to the well-being and performance of athletes. Its scope extends beyond mere injury treatment, encompassing a proactive approach to prevention. Specialists in sports medicine focus on developing strategies to safeguard athletes during training and competition, aiming to mitigate the risk of injuries. In the event of injuries, a collaborative team of critical players emerges. Physicians and orthopedic surgeons, armed with expertise in sports medicine, diagnose and treat sports-related injuries, with orthopedic surgeons handling more severe cases requiring surgical intervention. Physical therapists play a pivotal role in rehabilitation, designing personalized programs to facilitate a speedy and effective return to play. Additionally, sports trainers and coaches contribute significantly by actively preventing injury, providing immediate care, and guiding athletes through recovery.

At the Winter Olympic Games in Beijing 2022, the medical team noted 725 injuries and 1,119 illnesses while evaluating 35,537 athletes and non-athletes. That means there were about 24 injuries and 31 illnesses for every 1000 athletes and non-athletes. In simpler terms, 2.4% of the participants got hurt, and 3.1% fell ill at least once. This suggests that many athletes dealing with injuries might be a reason for the growth of the sports medicine market. Technological advancements heavily influence the sports medicine landscape. Diagnostic tools such as MRI and CT scans enable precise injury diagnosis, while rehabilitation benefits from advanced equipment that aids in targeted exercises and recovery. Wearable technology, including fitness trackers and bright clothing, further enhances the monitoring of athletes’ performance and health.

Pharmaceuticals and therapeutics constitute another crucial aspect of sports medicine. Specialized medications are prescribed for pain management, inflammation reduction, and muscle recovery. Additionally, regenerative medicine techniques like stem cell therapy and platelet-rich plasma (PRP) are gaining prominence for their potential in promoting healing. Global market trends underscore the increasing demand for sports medicine services, propelled by a rising engagement in sports and fitness activities. Investments in research and development drive continuous innovation, leading to the emergence of novel treatments, technologies, and rehabilitation methods. The integration of telemedicine is on the rise, providing athletes with remote consultations and monitoring and enhancing accessibility to sports medicine expertise.

Furthermore, the field of sports medicine faces challenges. The cost of accessing advanced services can be a barrier, particularly for amateur athletes. Moreover, an injury stigma persists, causing some athletes to delay seeking help out of fear of being sidelined or perceived as weak, thereby complicating the treatment process. The sports medicine market is a dynamic and evolving domain that harmonizes medical expertise, innovative technology, and a profound understanding of the physical demands of sports. Beyond addressing injuries, its ultimate goal is to empower athletes to pursue their passions with optimal health and performance.

Overview of Sports Medicine: Expertise, Training and Multidisciplinary Care

Sports medicine healthcare providers are specially trained to help injured individuals get back on their feet as quickly as possible. They excel in preventing injuries and illnesses in active people. While they do work with professional athletes, their expertise extends to children and teens in sports, adults maintaining personal fitness, and even those in physically demanding jobs, like construction.

Sports medicine isn’t a standalone medical specialty. Instead, most providers are certified in other areas, such as internal medicine, emergency medicine, family medicine, or pediatrics, before undergoing additional training in sports medicine. Pediatric sports medicine specialists focus on the unique needs of growing bodies and are typically board-certified in pediatrics or family medicine with further sports medicine training. Some sports medicine professionals also have surgical training, often as orthopedic surgeons.

In addition to medical doctors, sports medicine care teams often include:

• Physical Therapists: They aid in rehabilitation and recovery from injuries.
• Certified Athletic Trainers: These trainers create rehab exercise routines to help regain strength and develop conditioning programs to prevent future injuries.
• Nutritionists: They assist with weight management and provide dietary advice to support overall health and performance.

Recent Developments

• In March 2023, Arthrex, Inc. got the green light from the U.S. FDA for the TightRope Implant. It’s a tool for fixing bone injuries and is the only one approved for surgeries on kids’ ACLs.
• In January 2023, Enovis (IDJO, LLC) released DynoClip Quattro and DynaClip Delta bone staples. These staples are designed to make life easier for foot and ankle surgeons.
• In September 2022, Zimmer Biomet got the thumbs up from the U.S. FDA for its Identity Shoulder System. It’s used for different types of shoulder replacement surgeries.
• In February 2022, DePuy Synthes bought CrossRoads Extremity Systems, which provides solutions for foot and ankle issues. This purchase is helping to bring new and better ideas to foot doctors, bone specialists, and medical technology.

Sports Medicine Market Companies

• Stryker Corporation
• Smith & Nephew
• Zimmer Biomet
• Johnson & Johnson Medical
• Arthrex
• DJO Global
• Performance Health Holding Inc.
• Bauerfeind AG
• Mueller Sports Medicine

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/sports-medicine-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5107

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5106

In 2021, the National Institute of Health estimates that 36 states allow medical marijuana, but the rules for getting it vary. Even though it’s legal in many places, medical marijuana is highly recommended for chronic pain management.

Marijuana is a plant that is commonly used for recreational and medicinal purposes. It contains a chemical called THC, which is responsible for the “high” feeling. People may smoke, vape, or eat marijuana for various effects, including relaxation and pain relief. However, it’s important to note that its legal status varies across different places. Legal marijuana refers to the regulated cultivation, sale, and use of cannabis within the boundaries of specific laws. It’s a significant shift in how society views and manages the use of marijuana. The legalization can be categorized into two main types: recreational and medicinal.

In places where recreational marijuana is legal, adults can use it for non-medicinal purposes. This often involves regulations on age restrictions, permissible quantities, and locations for consumption. Legalizing marijuana for medicinal purposes means that doctors can prescribe it to treat certain medical conditions. This recognizes marijuana’s potential therapeutic benefits.

The Economic Impact of Marijuana Legalization in the United States

There is a growing movement in the United States advocating for the legalization of marijuana for both medicinal and recreational purposes. Many states have already enacted laws to this effect. The push for legalization is largely driven by the potential economic benefits, including increased tax revenues, job creation, and investment opportunities. Currently, 24 states, three territories, and the District of Columbia have legalized recreational marijuana use, while 38 states, three territories, and the District of Columbia permit medical marijuana use.

Impact on Tax Revenue

One of the most immediate benefits of marijuana legalization is the boost in tax revenue. In 2023, states collectively generated over $4.18 billion in tax revenue from marijuana sales. California led the way, collecting $1.1 billion in sales tax from cannabis. Washington and Colorado, the pioneers of recreational marijuana legalization, have seen substantial tax revenues since 2014. Washington amassed $4.1 billion, while Colorado collected $2.38 billion in marijuana tax revenue during this period.

Legalizing marijuana nationwide could further increase tax revenues across other states and at the federal level, enhancing the economic impact of legalization.

Legal Marijuana Market Companies

• Curaleaf Holdings Inc.
• Green Thumb Industries Inc.
• Canopy Growth Corporation
• Aurora Cannabis Inc.
• Maricann Inc.
• Jazz Pharmaceuticals, Inc.
• Organigram Holdings Inc.
• Controlled Environments Limited
• Lexaria Bioscience
• Tikun Olam

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/legal-marijuana-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5106

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Highlights from the U.S. Child Care Market Report:

• The U.S. child care market reached a size of $59.87 billion in 2023.
• It is expected to grow to $88.22 billion by 2033.
• The market is anticipated to experience significant growth, with a CAGR of 4.3% from 2024 to 2033.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5105

According to Scottish Government estimates, the number of registrations for funded Early Learning Child Care (ELC) increased by 8.6% in 2022, from 6,459 in 2021 to 7,017 in 2022, as the number of working parents has increased and the demand for child care services has risen.

Child care involves caring for children when their parents or guardians are unavailable. It goes beyond just keeping an eye on them – it includes providing a safe and nurturing environment where children can play, learn, and grow. U.S. child care can occur in daycare centers, preschools, or at home with a babysitter. The goal is to support the child’s development, ensuring they are happy, healthy, and learning new things while their parents are away.

The U.S. child care market is a dynamic and vital component of the nation’s social infrastructure. With a growing emphasis on early childhood education and the increasing number of working parents, the demand for quality child care services has surged in recent years. This blog aims to provide a comprehensive overview of the U.S. child care market, exploring key trends, challenges, and opportunities that define this intricate ecosystem. To understand the present, it’s essential to delve into the past. The history of child care in the U.S. reveals a gradual evolution from informal, community-based arrangements to the structured, regulated systems today. From the humble beginnings of neighborhood babysitters to the emergence of day-care centers, tracing this trajectory offers insights into societal shifts and changing family dynamics.

More girls attend school, stay longer, and do well, but some still face challenges like dropping out of early marriages and pregnancies. As they grow up, taking care of their family often makes it challenging for them to pursue higher education or work. Globally, many women can’t work due to unpaid care duties. This hurts girls and whole countries. Sadly, lots of families lack good child care. The World Bank says 40% of young kids (350 million) need child care but can’t get it. If we improve child care, it can benefit girls, families, businesses, and economies.

When the study kicked off, there was a bit of debate among the researchers about what exactly to label as “child care.” Some thought regular care from the father should count, while others argued that only care from non-parental figures should be included. After some discussion, they decided to encompass all consistent care provided by someone other than the mother. This covered care from relatives, a single caregiver in the child’s home, small group care at a caregiver’s place, and center-based care. Most of the info here focuses on the early years, up to age 4. Once kids hit 5 and start school, their child care landscape shifts. The researchers should have delved into the experiences of school-aged children in this study.

Additionally, these findings are interesting because they help us understand the different types of child care kids receive. It’s essential to consider these aspects, especially as the global market grows, impacting how families structure child care for their little ones.

Benefits of Family Child Care Center

Family U.S. child care centers have advantages like keeping kids of different ages from the same family together all day. Also, the children and the caregiver might have a shared cultural or language connection. These care setups are more accessible in areas where regular child care options are scarce, which is the case in more than half of the country. This model fits many families based on their needs and priorities.

U.S. Child Care Market Companies

• Bright Horizons Family Solutions
• KinderCare Learning Centers
• Learning Care Group
• Spring Education Group
• Care.com
• UrbanSitter
• The Learning Experience
• Kids ‘R’ Kids
• Goddard Franchisor LLC
• Cadence Education

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/us-child-care-market-size 

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5105

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Burn Care Market Report Highlights:

• The global burn care ignited a USD 2.73 billion market size in 2023.
• It is set to blaze USD 4.41 billion market by 2033.
• Burn care market is growing at a CAGR of 5.2% for the forecast period (2023 – 2033).
• Biologics are the rising stars, expected to scorch with a 7.1% CAGR by 2033.
• Advanced dressings were the hottest sellers in 2023, grabbing a 47% market share.
• Partial thickness burns took the biggest hit of 49% share in 2023.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5104

According to the World Health Organization, every year, 180000 deaths are caused globally by burns, which results in the focus on research and innovative burn care treatment.

In the U.S., over 500,000 people get treatment for burn injuries and serious skin wounds each year! Doctors often have to do surgery, taking skin from one part of the body to patch up severe wounds. But it’s a challenging process, and some patients need more skin for grafting. NIH-funded scientists have found that using a cool skin bioprinter might be a great alternative. They tested it on animals, and it worked well, showing that this technology can create a skin that looks and acts like the real deal. While it hasn’t been tried on people yet, it’s an exciting step toward healing serious skin wounds more easily.

Burn care is all about taking care of injuries caused by burns, ranging from minor to serious. When you get a burn, whether it’s from hot objects, chemicals, or fire, it can damage your skin and sometimes even deeper tissues. For minor burns, like a sunburn or a slight kitchen mishap, you can usually handle it with cool water, over-the-counter creams, and a bit of TLC. But when we’re talking about more severe burns, that’s when the pros step in. Doctors might need to perform surgeries, especially for severe burns. This could involve grafting, where they take skin from one part of your body and use it to cover the burn. However, this process can be intense, and only some have enough skin for grafting. Here’s where things get interesting. Scientists are exploring a futuristic approach using something called a skin bioprinter. So, burn care is this blend of traditional methods and innovative tech, all aimed at helping people heal from burns and severe skin injuries. It’s a fascinating field that keeps evolving to make the process smoother and more effective. The significant increase in the market is partly due to the severe health risks associated with burn cases.

The Rising Incidences of Burn Injuries

According to the American Burn Association (ABA), burn injuries account for more than 60% of all hospital admissions for immediate care in the United States. Additionally, the growing demand for less invasive methods of treating burns is expected to drive market growth. The rise in burn injuries and related deaths is a significant factor driving the global burn care market. Because of the large number of burn injuries and deaths, there is an increasing demand for burn treatment products.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/burn-care-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5104

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5103

According to Healthit.gov, in the transformative landscape of healthcare, a remarkable surge in Electronic Health Records (EHR) adoption has been witnessed, with an impressive 78% adoption rate among office-based physicians and an even 96% among non-federal acute care hospitals as of 2021.

Electronic Health Records (EHR) are comprehensive digital repositories of an individual’s health information. These records go beyond just a medical history; they encompass a patient’s entire healthcare journey. Within Electronic Health Records (EHR), you’ll find details about diagnoses, treatments, medications, immunizations, allergies, and even demographic information. One key advantage is accessibility. EHR allows authorized healthcare professionals to access your information securely, promoting seamless collaboration among healthcare providers. This accessibility enhances the continuity of care, ensuring your doctors have up-to-date and accurate information to make informed decisions.

Electronic Health Records (EHR)  also facilitate data sharing between various healthcare settings, like hospitals, clinics, and pharmacies. This interoperability reduces redundancies, minimizes errors, and streamlines processes. For instance, if you visit a specialist, they can quickly review your medical history and coordinate treatments more effectively. Additionally, Electronic Health Records (EHR) contribute to improved patient engagement. Some systems enable patients to access their health records, fostering a better understanding of their conditions and encouraging active participation in their healthcare journey. Data security is a paramount concern in Electronic Health Records (EHR). Robust encryption and authentication measures are in place to safeguard sensitive health information. This ensures that only authorized individuals have access to the data, maintaining patient privacy and complying with regulatory standards.

Furthermore, Electronic Health Records (EHR) revolutionize healthcare by digitizing and centralizing health information, fostering collaboration among healthcare providers, enhancing patient engagement, and prioritizing data security to provide efficient, personalized, and high-quality care. The global increase in the adoption of Electronic Health Records (EHR) is a response to these systems’ transformative impact on healthcare delivery, efficiency, patient outcomes, and compliance with evolving regulatory standards. As technology advances, the adoption of electronic health records is likely to expand further.

Recent Developments:

• In July 2023, NextGen Healthcare and the American Podiatric Medical Association joined forces to enhance their “NextGen Office” platform, focusing on podiatry blueprints that tackle diabetes and injuries.
• In June 2023, CPSI expanded its partnership with Mid Coast Health System, implementing EHR, accounts receivables, and IT-managed services at Crockett Medical Center in Texas. Other Mid Coast hospitals, like El Campo Memorial and Palacios Community Medical Center, have also adopted CPSI solutions.
• In May 2023, MEDITECH partnered with Canada Health Infoway to link up with their e-prescribing service, “Prescribell.” This collaboration enables Canadian prescribers to electronically send prescriptions from MEDITECH’s Expanse EHR to the patient’s chosen pharmacy, simplifying new prescriptions, renewals, and cancellations.
• In February 2023, King’s College Hospital in Dubai joined forces with Oracle Cerner to upgrade its electronic medical records system using Oracle Cloud services.

Electronic Health Records (EHR) Market Companies

• Epic Systems Corporation
• Allscripts Healthcare Solutions, Inc.
• McKesson Corporation
• GE Healthcare
• NextGen Healthcare, Inc.
• Athenahealth
• OpenEMR
• Siemens Healthineers AG
• eClinicalWorks
• Medical Information Technology, Inc.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/electronic-health-records-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5103

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5102

According to the American Cancer Society, approximately 1.8 million people were diagnosed with cancer, with over 600,000 people expected to die as a result of this challenging disease. Home infusion allows patients to manage cancer treatment actively, giving them greater control.

In 2020, the National Home Infusion Foundation Trends 2020 Report estimated that the fascinating world of home and specialty infusion caters to over 3.2 million patients annually. The COVID-19 pandemic hit a pause on elective surgeries, causing a dip in the need for follow-up home care. Thanks to cost-cutting by slashing inpatient stays and a buffet of infusion device options. Home infusion therapy (HIT) takes the healthcare party directly to a patient’s doorstep at home, nursing home, hospital or outpatient clinic. But, also, a knowledge gap looms between the home infusion experts and the clinicians, potentially leading to less-than-stellar outcomes. Let’s bridge that gap for optimal therapeutic adventures.

U.S. Home infusion therapy is like bringing the hospital to your home! It’s a specialized healthcare service where patients receive medications through a needle or catheter at home instead of going to a medical facility. This method is often used for conditions requiring ongoing treatments, like infections, chronic illnesses or pain management. A trained healthcare professional usually administers the infusions, ensuring patients can comfortably manage their treatment in the familiar environment of their own homes. It offers convenience and personalized care, making the healing process a bit easier.

Impact of COVID-19

The COVID-19 pandemic had challenges and opportunities for the U.S. home infusion therapy market. On the downside, the initial disruptions in healthcare systems worldwide affected the regular flow of services, including U.S. home infusion therapy. Patients were hesitant due to safety concerns and healthcare resources were strained. However, on a positive note, the pandemic emphasized the importance of home-based care and many patients and healthcare providers turned to home infusion therapy to minimize exposure. Telehealth services also played a crucial role in monitoring and managing treatments remotely. The flexibility and reduced infection risks associated with home infusion gained prominence, leading to a renewed appreciation for this personalized and patient-friendly approach to healthcare. As we adapt to a post-pandemic world, the home infusion therapy market is expected to grow as vital to accessible and patient-centered healthcare.

Internationally, the idea of getting cancer treatments at home has proven safe and effective for various patients and treatments. Around 5% to 10% of global patients opt for home administration, with even intensive chemotherapy being successfully done at home. It offers comparable care and enhances the overall experience for patients and caregivers while being more cost-effective. In the United States, the practice of delivering cancer drugs at home is not common. This reluctance is primarily due to ingrained preferences for outpatient or inpatient treatments among healthcare professionals and patients. Additionally, established health insurance and drug reimbursement policies contribute to this trend.

For Instance,

• Peon Medicine, a six-hospital health system in the Philadelphia region, handles over 17,000 new cancer patients annually. Surprisingly, only 670 were utilizing Penn Home Infusion Therapy as of February 2020, despite its proven safety and effectiveness for treatments like chemotherapy and hydration. It’s worth noting that the home infusion setting also provides a convenient way to manage exposure to COVID-19.

U.S. Home Infusion Therapy has Grown in Cancer Treatment

As cancer becomes more common, some people now need chemotherapy at home. This means getting the necessary treatment in their homes instead of going to a hospital. It helps make the process more convenient for patients. In 2020, nearly 43% of cancer diagnoses in men were attributed to prostate, lung and colorectal cancers. Similarly, for women, breast, lung and colorectal cancers made up about half of all new cancer cases in that year. It’s worth noting that the adoption of home infusion therapy has been on the rise, contributing to increased care for individuals dealing with these prevalent cancers.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/us-home-infusion-therapy-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5102

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5101

Key Takeaways

• By region, Asia Pacific dominated the insulin market in 2023.
• By region, North America is estimated to grow with the fastest CAGR during the forecast period.

Segmentation A (Drug)

• By product, the premixed long-acting segment held the largest market share in 2023.
• By product, the rapid-acting segment is anticipated to grow at the fastest rate during the forecast period.
• By source, the insulin analog segment dominated the market in 2023.
• By distribution channel, the retail pharmacies segment dominated the market in 2023.
• By distribution channel, the hospital pharmacies segment is expected to grow at the fastest rate during the forecast period.
• By application, the type 2 diabetes segment dominated the market in 2023.
• By application, the gestational diabetes segment is expected to grow significantly during the forecast period.

Segmentation B (Delivery Device)

• By delivery device, the insulin pens segment held the largest market share in 2023.
• By delivery device, the insulin pumps segment is anticipated to grow at the fastest rate during the forecast period.
• By distribution channel, the retail pharmacies segment dominated the market in 2023.
• By distribution channel, the hospital pharmacies segment is expected to grow at the fastest rate during the forecast period.
• By application, the type 2 diabetes segment dominated the market in 2023.
• By application, the gestational diabetes segment is expected to grow significantly during the forecast period.

Industry at a Glance

The insulin market deals with the development, production, distribution, and innovation of insulin for chronic conditions of diabetes. One kind of hormone is insulin. The body uses insulin to facilitate the entry of blood glucose into cells, giving them the energy they need to operate. One of the main factors contributing to the development of diabetes is ineffective insulin. An estimated 530 million persons worldwide are projected to have diabetes, with a global incidence of 10.5% among adults between the ages of 20 and 79. Approximately 98% of diabetes diagnoses worldwide are for type 2 diabetes. However, this percentage varies greatly between nations.

According to data from the Diabetes Surveillance System, around 11.3 percent of adults (37.3 million) had diabetes in 2022; of them, 28.7 million had been diagnosed, 8.5 million were anticipated to remain undiagnosed, and 95% had type 2 diabetes. Insulin is the most effective therapy for diabetes, a difficult condition. In both outpatient and inpatient settings, the care of diabetes requires an interprofessional team approach at all times. The usage of insulin is rising due to the rising incidence of diabetes, which fuels the expansion of the insulin market.

Insulin Market Top Companies

• Eli Lilly
• Novo Nordisk
• Sanofi
• Boehringer Ingelheim
• Biocon
• Lupin Ltd.
• Wockhardt Ltd.
• Becton, Dickinson and Company
• B. Braun SE

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/global-insulin-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5101

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Huntington’s Disease Treatment Market Report Highlights:

• Huntington’s disease treatment saw a USD 601 million market in 2022.
• It is projected to reach USD 1,217.10 million market by 2032.
• It is poised for a promising growth trajectory of 7.8% of CAGR.
• The diagnostic imaging segment ruled the market in 2022 with over 61% market share.
• Tetrabenzene drugs held the top spot in 2022, capturing 43% of the market.
• North America remained the kingpin in the huntington’s disease treatment market, with 46% dominance.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5100

Huntington’s disease affects an estimated 2.7 every 100,000 individuals The rising prevalence fosters demand for research and treatment management of huntington’s disease.

Huntington’s disease (HD) is an inherited condition where specific brain cells gradually break down, impacting movement control and various aspects of behavior and emotion. Individuals with huntington’s disease (HD) may experience involuntary dance-like movements called chorea, which can intensify when nervous or distracted. Symptoms typically emerge in middle-aged adults but can also affect children, albeit rarely. The disease progresses, leading to increased movement, balance and cognitive function challenges. In the early stages, signs may manifest as mild clumsiness, balance issues or cognitive and emotional difficulties. Some may face difficulties walking due to chorea, while others might become rigid or experience unusual, fixed postures, known as dystonia. Tremors, abnormal eye movements, slurred speech and problems with swallowing and eating are common physical changes. As HD advances, individuals may face weight loss, fatigue, seizures and eventually require assistance with mobility. Cognitive changes include issues with attention, judgment, decision-making and organizing tasks. Severe cognitive impairment may lead to dementia, hindering daily functioning. Despite these challenges, many people with huntington’s disease (HD) remain aware of their surroundings and can express emotions. Behavioral changes encompass mood swings, irritability, apathy, depression and anger, with some individuals experiencing persistent symptoms like suicidal thoughts and psychosis. Social withdrawal can occur, impacting participation in activities. It is essential to approach HD with empathy, recognizing it as a severe condition requiring comprehensive management. The global demand for effective treatments has increased as awareness of this challenging disorder grows.

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/huntingtons-disease-treatment-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5100

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5099

In 2023, according to the World Health Organization, it is estimated that around 50 million individuals are suffering from Epilepsy and showing a greater risk of premature death due to epilepsy. Medical cannabis hits high notes for Epilepsy, Chronic Pain Management and Rare Diseases.

Medical cannabis is obtained from the Cannabis Sativa plant and has been used for centuries due to its potential therapeutic benefits. Cannabis contains two main active compounds: Tetrahydrocannabinol (THC) and Cannabidiol (CBD). THC is known for its psychoactive properties, whereas CBD is non-psychoactive and has a variety of health benefits. The human body contains an endocannabinoid system (ECS), which regulates various physiological processes. Cannabinoids found in medical cannabis interact with receptors in the ECS, influencing processes such as pain perception, immunity and mood. One of the primary applications of medical cannabis is pain relief and it is used for various symptoms and diseases. THC can help alleviate chronic pain by altering how pain signals are processed in the brain. CBD, on the other hand, may have anti-inflammatory and analgesic properties without causing the “high” associated with THC. Medical cannabis is also utilized to manage nausea and vomiting, often in patients undergoing chemotherapy. THC can help reduce these symptoms and improve the quality of life for individuals undergoing cancer treatments.

In some cases, medical cannabis is prescribed for muscle spasms and spasticity associated with conditions like multiple sclerosis. The cannabinoids’ muscle-relaxant properties may provide relief for these symptoms. It’s crucial to highlight that the legal status of medical cannabis varies widely around the world and even within different regions of a country. Some places have legalized its use for medicinal purposes, while others still have strict regulations or complete prohibition. Before considering medical cannabis, individuals should consult with healthcare professionals to discuss potential benefits, risks and legal implications based on their specific health conditions and local regulations.

Medical Cannabis Market Analysis Survey, 2022

The DHHS center for medical cannabis surveyed participants in the state’s medical cannabis program. The survey aimed to gather feedback on the state’s medical cannabis sector regarding product access availability.

Additionally, medical cannabis, also known as medical marijuana, utilizes either the cannabis plant or its chemical components to address symptoms or medical conditions. While medical marijuana is available in forms similar to recreational use, there are also refined lab-made versions for specific health issues. Historically, cannabis use traces back to Central Asia or Western China, with documented instances dating back to 2800 BC in Emperor Shen Nung’s pharmacopeia. The cannabis plant contains over 100 cannabinoids, with THC and CBD being the primary ones used in medicine. THC induces the characteristic “high”, whether through smoking or ingesting cannabis-infused products. As of 2023, medical marijuana products were legally accessible in 38 states, three territories and the District of Columbia despite remaining prohibited under federal law.

The Role of Medical Cannabis in Treating Various Symptoms and Conditions

In states where medical marijuana is sanctioned, its approval extends to a diverse range of medical conditions, such as

• Severe and Persistent Pain
• Multiple Sclerosis
• Chemotherapy-Induced Nausea
• Epilepsy
• Alzheimer’s
• ALS
• HIV/AIDS
• Crohn’s Disease
• Glaucoma
• Migraines
• Anorexia
• Wasting Syndrome
• Irritable Bowel Syndrome
• Post-Traumatic Stress Disorder

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/medical-cannabis-market-size

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5099

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare